CVRX - CVRx, Inc.


7.52
0.790   10.505%

Share volume: 650,885
Last Updated: 04-28-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 1.01%

PREVIOUS CLOSE
CHG
CHG%

$6.73
0.79
0.12%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 8%
Dept financing 18%
Liquidity 75%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
16.05%
1 Month
-38.51%
3 Months
-55.37%
6 Months
-29.98%
1 Year
-50.79%
2 Year
-41.02%
Key data
Stock price
$7.52
P/E Ratio 
0.00
DAY RANGE
$6.85 - $7.91
EPS 
-$2.65
52 WEEK RANGE
$5.81 - $18.55
52 WEEK CHANGE
-$51.52
MARKET CAP 
307.421 M
YIELD 
N/A
SHARES OUTSTANDING 
21.786 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
1.51
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$367,665
AVERAGE 30 VOLUME 
$573,424
Company detail
CEO: Nadim Yared
Region: US
Website: cvrx.com
Employees: 160
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

CVRx, Inc. focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe and internationally.

Recent news
loading